A systematic review and meta-analysis on the real-world effectiveness of COVID-19 vaccines against infection, symptomatic and severe COVID-19 disease caused by …
H Mohammed, DD Pham-Tran, ZYM Yeoh, B Wang… - Vaccines, 2023 - mdpi.com
Real-world data on the effectiveness of COVID-19 vaccines against the Omicron variant (B.
1.1. 529) is limited. This systematic review aimed to investigate the real-world effectiveness …
1.1. 529) is limited. This systematic review aimed to investigate the real-world effectiveness …
Protection of the third-dose and fourth-dose mRNA vaccines against SARS-CoV-2 Omicron subvariant: a systematic review and meta-analysis
MO Rahman, T Kamigaki, MM Thandar, R Haruyama… - BMJ open, 2023 - bmjopen.bmj.com
Objectives The rapid spread of the SARS-CoV-2 Omicron variant has raised concerns
regarding waning vaccine-induced immunity and durability. We evaluated protection of the …
regarding waning vaccine-induced immunity and durability. We evaluated protection of the …
SARS-CoV-2 omicron (B. 1.1. 529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer: results from the OnCovid registry
A Cortellini, J Tabernero, U Mukherjee… - The Lancet …, 2023 - thelancet.com
Background COVID-19 sequelae can affect about 15% of patients with cancer who survive
the acute phase of SARS-CoV-2 infection and can substantially impair their survival and …
the acute phase of SARS-CoV-2 infection and can substantially impair their survival and …
Incidence and determinants of symptomatic and asymptomatic SARS-CoV-2 breakthrough infections after booster dose in a large European multicentric cohort of …
S Porru, MGL Monaco, G Spiteri, A Carta… - Journal of Epidemiology …, 2023 - Springer
Background SARS-CoV-2 breakthrough infections (BI) after vaccine booster dose are a
relevant public health issue. Methods Multicentric longitudinal cohort study within the …
relevant public health issue. Methods Multicentric longitudinal cohort study within the …
Improving nasal protection for preventing SARS-CoV-2 infection
Airborne pathogens, including SARS-CoV-2, are mainly contracted within the airway
pathways, especially in the nasal epithelia, where inhaled air is mostly filtered in resting …
pathways, especially in the nasal epithelia, where inhaled air is mostly filtered in resting …
Safety of COVID-19 vaccines in patients with autoimmune diseases, in patients with cardiac issues, and in the healthy population
L Frasca, G Ocone, R Palazzo - Pathogens, 2023 - mdpi.com
The coronavirus disease 2019 (COVID-19) has been a challenge for the whole world since
the beginning of 2020, and COVID-19 vaccines were considered crucial for disease …
the beginning of 2020, and COVID-19 vaccines were considered crucial for disease …
COVID-19 Vaccination Effectiveness in the General Population of an Italian Province: Two Years of Follow-Up
A Rosso, ME Flacco, G Soldato, G Di Martino… - Vaccines, 2023 - mdpi.com
We carried out a cohort study on the overall population of the province of Pescara, Italy, to
assess the real-world effectiveness of SARS-CoV-2 vaccination against infection, severe, or …
assess the real-world effectiveness of SARS-CoV-2 vaccination against infection, severe, or …
The COVID-19 Pandemic—A Potential Role for Antivirals in Mitigating Pandemics
The COVID-19 pandemic has served as a stark reminder that outbreaks of novel pathogens
(ie, those not previously encountered by humans) have always plagued mankind and will …
(ie, those not previously encountered by humans) have always plagued mankind and will …
The Scabbard of Excalibur: An Allegory on the Role of an Efficient and Effective Healthcare System under Universal Health Coverage during the Pandemic Response
H Noda - Healthcare, 2024 - mdpi.com
During the COVID-19 pandemic, while some countries succeeded in reducing their rate of
death after SARS-CoV-2 infection via vaccination by the end of 2021, some of them also …
death after SARS-CoV-2 infection via vaccination by the end of 2021, some of them also …
Effectiveness of mRNA booster vaccination against mild, moderate, and severe COVID-19 caused by the Omicron variant in a large, population-based, Norwegian …
I Laake, SN Skodvin, K Blix… - The Journal of …, 2022 - academic.oup.com
Background Understanding how booster vaccination can prevent moderate and severe
illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters …
illness without hospitalization is crucial to evaluate the full advantage of mRNA boosters …